以天然代谢物为目标的端粒RNA四重复合,以预防癌症
Gourav Choudhir1, Sushil Kumar2, Anuj Kumar3
1Department of Botany, Chaudhary Charan Singh University, Meerut, 250004 India.
In silico pharmacology
|November 29, 2024
概括
中的化合物斯特伦宁M,梅利奥利德K和基酸A显示出作为癌症治疗药物的潜力. 它们稳定了端粒G-四重复 (RG4) 结构,抑制了癌细胞的不朽性,并诱导了端粒的缩短.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌细胞通过端粒酶维护端粒重复来实现不朽.
- 端粒G-四重复 (RG4) 结构是抑制端粒酶活性的关键标.
- 自然产品为新型癌症治疗开发提供了一个有希望的途径.
研究的目的:
- 选非核酸菌代谢物以确定它们稳定RG4结构的能力.
- 为了研究与RG4.4选择的代谢物与RG4.4的分子相互作用和结合亲和力.
- 评估这些化合物在癌症治疗中的治疗潜力.
主要方法:
- 使用AutoDock Vina进行分子对接,以预测结合相互作用.
- 使用GROMACS进行分子动力学模拟 (250 ns),以评估复杂的稳定性.
- 有约束力的自由能量计算来量化相互作用强度.
主要成果:
- 斯特列宁M,梅列奥利德K和尚库酸A对RG4结构表现出强烈的结合亲和力.
- 这些代谢物在原子水平上与RG4表现出显著的非共价相互作用.
- 分子动力学模拟证实了RG4代谢物复合物的稳定性.
结论:
- 研究的代谢产物通过向端粒显示出作为新型抗癌剂的前景.
- 需要进一步的体外和体内研究来确定毒性,疗效和最佳剂量.
- 这些化合物可能被开发成用于癌症治疗的新疗法策略.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
99
03:38Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
1.4K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Telomeres and Telomerase
23.1K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.1K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Replication in Eukaryotes
13.2K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.2K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
